Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Hepatology|June 15, 2020
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertensionSabela Lens, Anna Baiges, Edilmar Alvarado-Tapias, et al.Gastroenterology|July 24, 2017
Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated CirrhosisSabela Lens, Edilmar Alvarado-Tapias, Zoe Mariño, et al.The American Journal of Gastroenterology|June 7, 2017
Interferon-Free Therapy in Elderly Patients With Advanced Liver DiseaseSabela Lens, Inmaculada Fernández, Sergio Rodríguez-Tajes, et al.Hepatology (Baltimore, Md.)|November 13, 2008
Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosisPedro Zapater, Rubén Francés, José M González-Navajas, et al.Journal of Hepatology|January 27, 2019
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodulesZoe Mariño, Anna Darnell, Sabela Lens, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 31, 2018
Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohortMarc Puigvehí, Beatriz De Cuenca, Ana Viu, et al.Journal of Hepatology|February 13, 2017
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohortJose Luis Calleja, Javier Crespo, Diego Rincón, et al.Journal of Hepatology|June 17, 2019
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAsJordi Llaneras, Mar Riveiro-Barciela, Sabela Lens, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2017
High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4Zoe Mariño, Juan M Pascasio-Acevedo, Adolfo Gallego, et al.Antiviral Research|December 21, 2019
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failureQian Chen, Celia Perales, María Eugenia Soria, et al.Pageof 4